Table 3. Predictors of intensive care/high dependency unit admission and prolonged length of stay in children (< 18 years) and adults with RSV disease, Australia, 2024 (n = 3,998).
| Variables | Crude OR | 95% CI | p value | Adjusted ORa | 95% CI | p value | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Predictors of ICU and HDU admission | ||||||||||
| Children | ||||||||||
| Age < 6 months | 1.79 | 1.34–2.38 | < 0.001 | 2.71 | 1.97–3.73 | < 0.001 | ||||
| Male sex | 1.11 | 0.84–1.47 | 0.472 | NS | ||||||
| First Nations statusb | 1.51 | 0.91–2.50 | 0.108 | NS | ||||||
| Any underlying medical condition | 2.56 | 1.94–3.40 | < 0.001 | NS | ||||||
| Preterm birth | 2.91 | 2.10–4.04 | < 0.001 | 2.03 | 1.34–3.07 | 0.001 | ||||
| Cardiac disease | 4.06 | 2.67–6.18 | < 0.001 | 1.83 | 1.13–2.98 | 0.014 | ||||
| Respiratory disease | 2.34 | 1.67–3.29 | < 0.001 | NS | ||||||
| Neurological disease | 4.44 | 2.89–6.81 | < 0.001 | 2.27 | 1.37–3.77 | 0.001 | ||||
| Genetic disorder | 6.51 | 4.17–10.17 | < 0.001 | 3.69 | 2.17–6.27 | < 0.001 | ||||
| Metabolic disorder excluding diabetes | 7.76 | 2.32–26.00 | 0.001 | 4.55 | 1.16–17.82 | 0.030 | ||||
| Adults | ||||||||||
| Age ≥ 75 years | 0.36 | 0.19–0.69 | 0.002 | 0.40 | 0.21–0.78 | 0.007 | ||||
| Male sex | 0.74 | 0.42–1.29 | 0.278 | NS | ||||||
| First Nations statusb | 1.98 | 0.94–4.16 | 0.070 | NS | ||||||
| Respiratory disease | 3.20 | 1.79–5.73 | < 0.001 | 3.16 | 1.75–5.70 | < 0.001 | ||||
| Predictors of prolonged length of stay | ||||||||||
| Children | ||||||||||
| Age < 6 months | 1.26 | 1.07–1.49 | 0.006 | 1.54 | 1.36–1.73 | < 0.001 | ||||
| Male sex | 0.96 | 0.88–1.05 | 0.346 | NS | ||||||
| First Nations statusb | 1.17 | 0.97–1.40 | 0.096 | 1.21 | 1.04–1.42 | 0.016 | ||||
| Any underlying medical condition | 1.92 | 1.51–2.43 | < 0.001 | 1.40 | 1.27–1.54 | < 0.001 | ||||
| Preterm birth | 1.58 | 1.17–2.15 | 0.003 | NS | ||||||
| Cardiac disease | 2.31 | 1.86–2.88 | < 0.001 | 1.57 | 1.31–1.87 | < 0.001 | ||||
| Respiratory disease | 1.49 | 1.22–1.82 | < 0.001 | NS | ||||||
| Neurological disease | 2.42 | 1.88–3.11 | < 0.001 | 1.96 | 1.48–2.60 | < 0.001 | ||||
| Malignancy | 2.99 | 2.01–4.44 | < 0.001 | 1.94 | 1.44–2.59 | < 0.001 | ||||
| Immunosuppression | 2.75 | 2.05–3.69 | < 0.001 | 1.49 | 1.08–2.07 | 0.016 | ||||
| Genetic disorder | 2.08 | 1.54–2.79 | < 0.001 | NS | ||||||
| Metabolic disorder excluding diabetes | 2.35 | 1.21–4.58 | 0.012 | NS | ||||||
| Adults | ||||||||||
| Age ≥ 75 years | 1.28 | 1.00–1.64 | < 0.001 | NS | ||||||
| Male sex | 1.06 | 0.92–1.22 | 0.408 | NS | ||||||
| First Nations statusb | 0.66 | 0.51–0.86 | 0.002 | NS | ||||||
| Any underlying medical condition | 1.27 | 0.99–1.64 | 0.063 | NS | ||||||
| Cardiac disease | 1.19 | 0.99–1.43 | 0.062 | 1.15 | 1.00–1.31 | 0.038 | ||||
| Malignancy | 1.38 | 0.06–1.79 | 0.018 | 1.28 | 1.00–1.65 | 0.048 | ||||
| Immunosuppression | 1.19 | 1.00–1.43 | 0.049 | NS | ||||||
| Diabetes mellitus | 0.83 | 0.70– 0.99 | 0.034 | 0.83 | 0.72–0.96 | 0.011 | ||||
CI: confidence interval; HCU: high dependency unit; ICU: intensive care unit; OR: odds ratio; RSV: respiratory syncytial virus.
a In addition to age, sex and First Nations status, factors associated with p value < 0.1 in univariate models were included in the multivariable model.
b First Nations status included all Aboriginal Australian and Torres Strait Islander people based on self-report on medical records.
Children < 18 years and adults ≤ 18 years. Reference variables include all others in the cohort.